Revision D·E·J Night Face Cream: the retinol detail to bring into care

The listing identifies D·E·J Night Face Cream® in a 0.5 oz size. Its own comparison names D·E·J Face Cream, Daily Boosting Serum and Retinol Complete 1.0 as separate items with different advertised concerns. A reference to “the Revision cream” could therefore leave the other person looking at the wrong product. Exact Night listing Revision product comparison

The Night name is useful when describing an existing product or asking about a proposed purchase. It does not establish that the day cream has the same retinol, that another serum’s findings apply, or that an earlier product record describes this version. The prescription questions guide follows that same identity question into a prescription discussion, where the final supplied preparation matters.

Revision labels the ingredient “Time-Released 0.25% Retinol” and describes microencapsulation. It also names bakuchiol, the DEJ Targeting Blend, and prebiotics plus postbiotics. The company presents the combination as supporting appearance benefits while limiting dryness or irritation. These are statements about the named product’s design and claimed performance. Retinol and blend descriptions

The 0.25% figure is attached to retinol. It does not describe every component, establish a laboratory result for the container, or provide a conversion to another facial treatment. Bringing the precise name and percentage into the conversation is more informative than using “gentle retinol” as though that phrase could settle what a particular person should use.

The page advertises smoother-looking fine lines, better elasticity, refined texture and less visible pore appearance. It also discusses photodamage and the skin microbiome. These are several different proposed outcomes, and a reader may be interested in only one of them. The returned information does not identify a participant group, comparator or numerical Night-cream result that would let us quantify the expected change. Revision benefit wording

FDA distinguishes appearance-related cosmetic purposes from intended uses involving disease or the body’s structure and function. That framework helps explain why product wording matters; it does not provide an agency assessment of this cream. A broad word such as renewal should not be used to supply an unreported exposure measurement or a personal assurance. FDA intended-use explanation

A “Full Ingredient List” heading appears in the returned product text, followed by the next benefit section without an actual complete list. The named highlights are useful, but they cannot identify every ingredient of the preparation. This limitation concerns the information obtained for this review; it does not establish that no fuller declaration exists on a package or elsewhere. Ingredient-list heading Named highlights

A discussion about a previous reaction, an unfamiliar ingredient or an existing facial prescription would benefit from the complete current declaration. It would be premature to choose a cause of irritation from the highlights alone. The exact product information can be clarified through the responsible professional or manufacturer without guessing the missing base or treating a blend name as a formula.

The reviewed listing posts $80 for the 0.5 oz Night cream. That identifies the commercial option presented on the page. It does not tell us how long the preparation would last for a particular person, what another package would cost, or whether the product is worth more clinically than a less expensive moisturizer. No purchase, delivery or supplied container was inspected. Posted size and price

The American Academy of Dermatology notes that price does not reliably determine effectiveness. That is useful context for a conversation about priorities: the specific concern and available product information deserve attention alongside the charge. The review cannot turn a posted price into a promise of improvement or compare cost per treatment from an unverified pattern of use. AAD price and expectation context

Fine lines, rough texture and dry-looking skin can describe different observations. Revision’s page groups them within a broader appearance story. AAD explains that moisturizing traps water and may reduce the appearance of some fine lines. This gives hydration a defined role without proving Revision’s separate retinol or microbiome claims. Night-cream concerns AAD moisture explanation

A useful conversation can stay with what was actually noticed and what the reader wants explained. Other product discussions are available in the ALASTIN review and the NEOCUTIS review. Those links offer separate records to read; they do not supply a comparative result for D·E·J Night or decide which product belongs in an individual’s care.

The Night cream’s exact identity matters most when the discussion already includes another facial treatment. FDA’s medication-list guidance concerns communicating prescription and nonprescription products so professionals can understand the wider context. It does not perform an interaction assessment for this cream. The medication-list conversation guide keeps that responsibility clear. FDA record guidance

AAD’s discussion of irritation also distinguishes ordinary product advice from care directed by a dermatologist. Neither Revision’s tolerance language nor this review supplies clearance for a combination. Our guide to facial estriol and menopause treatment keeps an appearance-care product separate from a hormone-treatment decision. The practical question remains what information the treating professional needs about the Night cream, the other named products and the concern prompting the conversation. AAD professional-care context